Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy (Q44475976)

3 December 2017

Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy (English)

1 reference

3 December 2017

1 reference

R Houston Thompson

1

1 reference

3 December 2017

John C Cheville

2

1 reference

3 December 2017

Christine M Lohse

3

1 reference

3 December 2017

W Scott Webster

4

1 reference

3 December 2017

Horst Zincke

5

1 reference

3 December 2017

Eugene D Kwon

6

1 reference

3 December 2017

Igor Frank

7

1 reference

3 December 2017

Michael L Blute

8

1 reference

3 December 2017

Bradley C Leibovich

9

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

3 December 2017

1 reference

3 December 2017

104

1 reference

3 December 2017

1

1 reference

3 December 2017

53-60

1 reference

Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different?

3 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

The process for continuous improvement of the TNM classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Adrenal metastases from renal cell carcinoma: role of ipsilateral adrenalectomy and definition of stage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

The Heidelberg classification of renal cell tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Adrenocortical carcinoma: diagnosis, evaluation and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Improved prognostication of renal cell carcinoma using an integrated staging system

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21125

7 January 2021

Identifiers

DOI

10.1002/CNCR.21125

1 reference

3 December 2017

1 reference